Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab
NCT01752855
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
New formulation adalimumab
Sponsor
AbbVie (prior sponsor, Abbott)